Previous Close | 0.0400 |
Open | 0.0400 |
Bid | 0.0000 |
Ask | 0.1500 |
Strike | 1.50 |
Expire Date | 2025-01-17 |
Day's Range | 0.0400 - 0.0400 |
Contract Range | N/A |
Volume | |
Open Interest | 447 |
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended September 30, 2024. The Company now expects revenue for the third quarter of 2024 to be between $6.5 and $6.8 million, down from prior guidance of between $7.9 and $8.9 million. Cash, cash equivalents, available-for-sale securities, and restricted cash were approximately $23.3 million as of September 30, 2024, of which $11.4 million was subject to ce
Despite a revenue dip, Bionano Genomics Inc (BNGO) sees promising growth in its OGM installed base and strategic partnerships.
Special Meeting of Stockholders Adjourned Due to Lack of QuorumSAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that it has adjourned its Special Meeting of Stockholders held on October 2, 2024 (the “Special Meeting”) because a quorum was not present at the time of meeting. Based on preliminary reports as of October 2, 2024, only 22.5% of total shares outstanding as of the record date have submitted their votes, whereas 33.3% of total shares outs